Skip to main content
Naoto Ueno, MD, Oncology, Honolulu, HI

NaotoUenoMDMD, PhD(He/Him)

Oncology Honolulu, HI

Breast Cancer

University of Hawaiʻi Cancer Center Director Professor of Medicine

Dr. Ueno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ueno's full profile

Already have an account?

  • Office

    701 Ilalo Street, Room 622
    Honolulu, HI 96813
    Phone+1 808-586-3013

Summary

  • I am a board-certified internist and medical oncologist. I specialize in taking care of patients with inflammatory breast cancer, triple negative breast cancer, metastatic breast cancer, and bone metastasis. I have a passion to provide the best care to my patients.

Education & Training

  • UT Graduate School of Biomedical Science
    UT Graduate School of Biomedical SciencePhD, Cancer Biology, 1994 - 1999
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1990 - 1993
  • Other
    OtherClass of 1989

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 2022 - 2026
  • TX State Medical License
    TX State Medical License 1993 - 2026
  • FL State Medical License
    FL State Medical License 2021 - 2023
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regents’ Outstanding Teaching Award The University of Texas System, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Rates of Immune Cell Infiltration in Patients with Triple-Negative Breast Cancer by Molecular Subtype  
    Wendy A Woodward, Naoto T Ueno, Savitri Krishnamurthy, Bora Lim, PLoS One
  • Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer  
    Michael C Stauder, Anthony Lucci, Wendy A Woodward, Bora Lim, Naoto T Ueno, ScienceDirect

Lectures

  • Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

  • Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
  • Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
  • Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
  • Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
  • An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
  • An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
  • My Methodology: How I Treat Inflammatory Breast CancerApril 2018
  • 5 Items Patients (And You) Should Complete to Prepare for the End of LifeJanuary 2018
  • Prior Systemic Treatment Increased the Incidence of Somatic Mutations in Metastatic Breast CancerJanuary 2018
  • Join now to see all

Press Mentions

  • HER2-Low Breast Cancer: Despite New Data, Questions Persist
    HER2-Low Breast Cancer: Despite New Data, Questions PersistOctober 24th, 2024
  • Five Questions with Dr. Naoto Ueno, UH Cancer Center's New Director
    Five Questions with Dr. Naoto Ueno, UH Cancer Center's New DirectorJanuary 30th, 2023
  • MD Anderson Research Highlights for December 19, 2022
    MD Anderson Research Highlights for December 19, 2022December 19th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Japanese